Shandong Sinobioway Biomedicine Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.00%

Shandong Sinobioway Biomedicine Co Ltd (002581) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Shandong Sinobioway Biomedicine Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥100.00

≈ $14.63 USD Cash + Short-term Investments

Total Assets

CN¥2.21 Billion

≈ $324.07 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2018)

This chart shows how Shandong Sinobioway Biomedicine Co Ltd's Asset Resilience Ratio has changed over time. See Shandong Sinobioway Biomedicine Co Ltd book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Shandong Sinobioway Biomedicine Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shandong Sinobioway Biomedicine Co Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥100.00	0.0%
Total Liquid Assets	CN¥100.00	0.00%

Asset Resilience Insights

Limited Liquidity: Shandong Sinobioway Biomedicine Co Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shandong Sinobioway Biomedicine Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shandong Sinobioway Biomedicine Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Shandong Sinobioway Biomedicine Co Ltd (2018–2018)

The table below shows the annual Asset Resilience Ratio data for Shandong Sinobioway Biomedicine Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2018-12-31	3.03%	CN¥130.00 Million ≈ $19.02 Million	CN¥4.29 Billion ≈ $628.26 Million	--

pp = percentage points

About Shandong Sinobioway Biomedicine Co Ltd

SHE:002581 China Drug Manufacturers - Specialty & Generic

Market Cap

$651.65 Million

CN¥4.45 Billion CNY

Market Cap Rank

#11189 Global

#3347 in China

Share Price

CN¥6.75

Change (1 day)

-5.06%

52-Week Range

CN¥6.75 - CN¥11.02

All Time High

CN¥39.86